Boston Children's Hospital at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Boston Children's Hospital brings 3 presentations to ASH 2026 in New Orleans. Its program centres on inherited and immune blood disorders, from genetic testing for neutropenia to cold agglutinin disease and inherited bone marrow failure. It also covers transfusion planning before transplant for sickle cell patients who have formed antibodies to donor blood.
| Organization | ASH 2026 Attendance |
|---|---|
Boston Children's Hospital Boston, MA | |
Pediatric teaching hospital of Harvard Medical School, with hematology, oncology and stem cell transplant care through Dana-Farber/Boston Children's. | Talk New Frontiers in RNA Biology Small RNAs that carry sugar chains and sit on the cell surface, how chemistry finds them, and what they mean for immunity. Talk Neutropenia Uncovered: The Role of Genetic Testing Genetic testing for low neutrophil counts, covering which patients to test, how to read inherited and acquired variants, and what results mean for care. Talk Pre-Transplant Transfusion Strategies in Alloimmunized Patients with Sickle Cell Disease Transfusion planning, including red cell exchange, for antibody-sensitized sickle cell patients before transplant or gene therapy, and hemolysis afterward. Session Tailored Transfusion Strategies for Alloimmunized Patients Transfusion for sickle cell disease patients with antibodies against donor blood, from pre-transplant planning to finding matched units and treating reactions. |
Instantly find 20 buyers from Boston Children's Hospital
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction